188 related articles for article (PubMed ID: 9122188)
21. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor.
Xu BC; Wang X; Darus CJ; Kopchick JJ
J Biol Chem; 1996 Aug; 271(33):19768-73. PubMed ID: 8702683
[TBL] [Abstract][Full Text] [Related]
22. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
23. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
Liu X; Robinson GW; Hennighausen L
Mol Endocrinol; 1996 Dec; 10(12):1496-506. PubMed ID: 8961260
[TBL] [Abstract][Full Text] [Related]
24. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.
Gouilleux F; Pallard C; Dusanter-Fourt I; Wakao H; Haldosen LA; Norstedt G; Levy D; Groner B
EMBO J; 1995 May; 14(9):2005-13. PubMed ID: 7744007
[TBL] [Abstract][Full Text] [Related]
25. Lactogenic hormone activation of Stat5 and transcription of the beta-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity.
Wartmann M; Cella N; Hofer P; Groner B; Liu X; Hennighausen L; Hynes NE
J Biol Chem; 1996 Dec; 271(50):31863-8. PubMed ID: 8943229
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone, but not prolactin, maintains, low-level activation of STAT5a and STAT5b in female rat liver.
Choi HK; Waxman DJ
Endocrinology; 1999 Nov; 140(11):5126-35. PubMed ID: 10537141
[TBL] [Abstract][Full Text] [Related]
27. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
28. Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in Kym-1 rhabdomyosarcoma cells.
Storz P; Döppler H; Pfizenmaier K; Müller G
FEBS Lett; 1999 Dec; 464(3):159-63. PubMed ID: 10618497
[TBL] [Abstract][Full Text] [Related]
29. Naturally occurring dominant negative variants of Stat5.
Wang D; Stravopodis D; Teglund S; Kitazawa J; Ihle JN
Mol Cell Biol; 1996 Nov; 16(11):6141-8. PubMed ID: 8887644
[TBL] [Abstract][Full Text] [Related]
30. Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation.
Kong M; Wang CS; Donoghue DJ
J Biol Chem; 2002 May; 277(18):15962-70. PubMed ID: 11827956
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocortiocoid receptor in mammary cells.
Cella N; Groner B; Hynes NE
Mol Cell Biol; 1998 Apr; 18(4):1783-92. PubMed ID: 9528750
[TBL] [Abstract][Full Text] [Related]
32. CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity.
Peng B; Sutherland KD; Sum EY; Olayioye M; Wittlin S; Tang TK; Lindeman GJ; Visvader JE
Mol Endocrinol; 2002 Sep; 16(9):2019-33. PubMed ID: 12198240
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone pulse-activated STAT5 signalling: a unique regulatory mechanism governing sexual dimorphism of liver gene expression.
Waxman DJ
Novartis Found Symp; 2000; 227():61-74; discussion 75-81. PubMed ID: 10752065
[TBL] [Abstract][Full Text] [Related]
34. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
35. Hydrophobic residues Phe751 and Leu753 are essential for STAT5 transcriptional activity.
Callus BA; Mathey-Prevot B
J Biol Chem; 2000 Jun; 275(22):16954-62. PubMed ID: 10748177
[TBL] [Abstract][Full Text] [Related]
36. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
Lischke A; Moriggl R; Brändlein S; Berchtold S; Kammer W; Sebald W; Groner B; Liu X; Hennighausen L; Friedrich K
J Biol Chem; 1998 Nov; 273(47):31222-9. PubMed ID: 9813029
[TBL] [Abstract][Full Text] [Related]
37. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
[TBL] [Abstract][Full Text] [Related]
38. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
Pezet A; Ferrag F; Kelly PA; Edery M
J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
[TBL] [Abstract][Full Text] [Related]
40. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
